For instance, the glycoprotein CD147 was shown to recruit E3 ligase CBLL1 for ECAD degradation, resulting in tumor progression.[25] Such evidence suggests that loss of ECAD can be induced at both the mRNA and protein levels, but which pathway is preferential at a given circumstance remains to be clarified. The gene discussed is CBLL1; the disease is neoplasm.